United States · 
Who invested in KaliVir Immunotherapeutics?
KaliVir Immunotherapeutics's investors include Premier Partners.
United States · Series A startup
Who invested in KaliVir Immunotherapeutics
Funding summaryUpdated 26 Oct 2026
$14Mraised across 1 round since 2026, from 1 source
- Latest round
- Series A, $14MAug 2026
- Investors
- 1
The rounds
- Aug 2026
Founders and team
From KaliVir Immunotherapeutics's own website: 5 on the team.
- Mayo ClinicChief Executive Officer
- Adina PelusioChief Development Officer
- Schond GreenwayChief Financial Officer
- Steve MoonDirector
- Tom LeonardDirector
AdvisersBright Peak Therapeutics
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about KaliVir Immunotherapeutics
How much has KaliVir Immunotherapeutics raised?
KaliVir Immunotherapeutics has raised $14M across 1 round since 2026.
When did KaliVir Immunotherapeutics last raise?
KaliVir Immunotherapeutics's most recent round was a Series A of $14M in Aug 2026.
What was KaliVir Immunotherapeutics's biggest round?
Its most recent round, $14M in Aug 2026, is also its largest on record.
Who backed KaliVir Immunotherapeutics first?
KaliVir Immunotherapeutics's first round on record, in Aug 2026, was backed by Premier Partners.
What stage is KaliVir Immunotherapeutics at?
KaliVir Immunotherapeutics's latest named round is a Series A, in Aug 2026.
Where is KaliVir Immunotherapeutics based?
KaliVir Immunotherapeutics is based in the United States.
Companies like KaliVir Immunotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.